TheProfitWatch

ORIC - Oric Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.4 0.23 (1.72%) --- 0.0 (0.0%) -0.54 (-3.81%) 0.06 (0.45%) 0.58 (4.36%) -0.55 (-3.88%) -0.55 (-3.88%)

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.47
Diluted EPS:
-0.47
Basic P/E:
-29.0
Diluted P/E:
-29.0
RSI(14) 1m:
0.0
VWAP:
13.63
RVol:
0.764

Events

Period Kind Movement Occurred At
1m Price increase 1m 13.69 +0.14 (+1.03%) Oct 15 10:09
1m Price increase 1m 13.48 +0.14 (+1.06%) Oct 15 09:39

Related News